A type of immune cell called ‘dark microglia’ could contribute to neurodegeneration by producing lipids that damage neurons, say researchers led by Pinar Ayata at the City University of New York.

Re “Fraud Has Delayed a Cure for Alzheimer’s,” by Charles Piller (Opinion guest essay, Jan. 26): Mr. Piller’s essay highlights a few high-profile cases of individuals accused of scientific misconduct ...

There is no single, easy test to diagnose Alzheimer’s, but a new review of 18 scientific studies confirms that a simple blood ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...

Mr. Piller is an investigative journalist for Science. This essay is adapted from his upcoming book, “Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s.” Jan. 24, 2025 Medical ...

Alzheimer's disease (AD), the most common form of dementia, continues to remain one of modern medicine's greatest challenges. This progressive neurodegenerative disorder affects millions of people ...

A new review highlights five major ways microplastics can harm the brain, raising concerns that they may worsen ...

Alzheimer’s disease research and drug development is evolving at a rapid pace. Decades of research has led to the approval of the first disease-modifying drugs and new pathological discoveries. The ...

For the first time in nearly three decades, experts have created a set of guidelines to better diagnose Alzheimer’s disease in the clinic. The advice also helps doctors identify the earliest signs of ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...